Factorytalk co., ltd.
This article highlights that with the Thailand 4.0 scheme, Factorytalk is optimistic about the investment opportunities and is keen on leveraging the support of the BOI to expand its operations and target customers.
Mr. David Holt, the Managing Director of Factorytalk, said that “Factorytalk is keen on taking advantage of the investment opportunities offered by Thailand’s growing life science sector and pharmaceutical industry, which has been stimulated by the Thailand’s Industry 4.0 initiative. The company is particularly interested in biotech, medical devices, cell & gene therapies, and health tech, which are among the target areas of Thailand 4.0.”
Moreover, Factorytalk is aware that one of the major concerns facing regulated industries such as pharmaceuticals is the high cost of traditional software systems. To tackle this issue, FactoryTalk has created cost-effective products that deliver world-class solutions and the advantages of digitalization to regulated manufacturing firms. The company aims to assist companies in Thailand and the surrounding regions in digitizing their operations, thereby enhancing efficiency, quality, and competitiveness.
Read the full article: